Patent · US Expired

Pentapeptide compounds and uses related thereto

US6884869B2 · kind B2 · utility

278Cited by
25References
2Claims
0Family size

Assignee

Inventors

Key dates

Filing dateNov 1, 2001
Grant dateApr 26, 2005
Priority date
Expiry dateMay 28, 2023

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K38/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Pentapeptide compounds are disclosed. The compounds have biological activity, e.g., cytotoxicity. Prodrugs having targeting groups and pentapeptide moieities, as well as precursors thereof are also disclosed. For example, precursors having a reactive linker that can serve as a reaction site for joining to a targeting agent, e.g., an antibody, as disclosed.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.